Skip to main content
Journal cover image

Discontinuation of PEG-ADA replacement therapy in a patient with ADA-deficiency previously treated with retroviral-mediated, T cell-directed gene therapy

Publication ,  Conference
Otsu, M; Ichimura, R; Yoshida, J; Hatano, N; Kobayashi, I; Kawamura, N; Ariga, T; Okano, M; Kobayashi, K; Hershfield, MS; Sakiyama, Y
Published in: MOLECULAR THERAPY
May 1, 2003

Duke Scholars

Published In

MOLECULAR THERAPY

ISSN

1525-0016

Publication Date

May 1, 2003

Volume

7

Issue

5

Start / End Page

S392 / S393

Location

WASHINGTON, D.C.

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE

Conference Name

6th Annual Meeting of the American-Society-of-Gene-Therapy

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Otsu, M., Ichimura, R., Yoshida, J., Hatano, N., Kobayashi, I., Kawamura, N., … Sakiyama, Y. (2003). Discontinuation of PEG-ADA replacement therapy in a patient with ADA-deficiency previously treated with retroviral-mediated, T cell-directed gene therapy. In MOLECULAR THERAPY (Vol. 7, pp. S392–S393). WASHINGTON, D.C.: ACADEMIC PRESS INC ELSEVIER SCIENCE.
Otsu, M., R. Ichimura, J. Yoshida, N. Hatano, I. Kobayashi, N. Kawamura, T. Ariga, et al. “Discontinuation of PEG-ADA replacement therapy in a patient with ADA-deficiency previously treated with retroviral-mediated, T cell-directed gene therapy.” In MOLECULAR THERAPY, 7:S392–93. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2003.
Otsu M, Ichimura R, Yoshida J, Hatano N, Kobayashi I, Kawamura N, et al. Discontinuation of PEG-ADA replacement therapy in a patient with ADA-deficiency previously treated with retroviral-mediated, T cell-directed gene therapy. In: MOLECULAR THERAPY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2003. p. S392–3.
Otsu, M., et al. “Discontinuation of PEG-ADA replacement therapy in a patient with ADA-deficiency previously treated with retroviral-mediated, T cell-directed gene therapy.” MOLECULAR THERAPY, vol. 7, no. 5, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2003, pp. S392–93.
Otsu M, Ichimura R, Yoshida J, Hatano N, Kobayashi I, Kawamura N, Ariga T, Okano M, Kobayashi K, Hershfield MS, Sakiyama Y. Discontinuation of PEG-ADA replacement therapy in a patient with ADA-deficiency previously treated with retroviral-mediated, T cell-directed gene therapy. MOLECULAR THERAPY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2003. p. S392–S393.
Journal cover image

Published In

MOLECULAR THERAPY

ISSN

1525-0016

Publication Date

May 1, 2003

Volume

7

Issue

5

Start / End Page

S392 / S393

Location

WASHINGTON, D.C.

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE

Conference Name

6th Annual Meeting of the American-Society-of-Gene-Therapy

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences